Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-049394
Filing Date
2025-05-15
Accepted
2025-05-15 16:03:22
Documents
1
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2514731-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2514731-4_4seq1.xml 4 18884
  Complete submission text file 0001104659-25-049394.txt   20449
Mailing Address C/O OCERA THERAPUETICS 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301
Business Address
James Steven P (Reporting) CIK: 0001243025 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38582 | Film No.: 25952510

Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Issuer) CIK: 0001564824 (see all company filings)

EIN.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)